Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment
Clinical trial NCT05599932 · COMPLETED
Trial details
- NCT number
- NCT05599932
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2023-09-18
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.